Literature DB >> 8113757

Antigenic heterogeneity of the attachment protein of bovine respiratory syncytial virus.

J Furze1, G Wertz, R Lerch, G Taylor.   

Abstract

A panel of 23 monoclonal antibodies (MAbs) specific for the attachment (G) glycoprotein of bovine respiratory syncytial virus (BRS virus), recognizing seven antigenic areas on the G protein, was used to determine the antigenic heterogeneity among 19 BRS viruses isolated over a 20 year period from various parts of the world. The pattern of reactivity of the isolates, as determined by ELISA, identified two major subgroups of BRSV. This finding was confirmed by radioimmunoprecipitation of the G protein by the MAbs and was also demonstrated using polyclonal sera obtained from calves hyperimmunized with BRS virus strains from each subgroup. The subgroups could also be differentiated by differences in the apparent M(r) of the fusion (F) glycoprotein and its cleavage products. The apparent M(r)s of the F0, F1 and F2 polypeptides were 73K, 46K and 17K for subgroup A strains and 77K, 46K and 23K for subgroup B strains. These studies provide evidence for two major lineages of BRS virus, similar to the situation with human RS virus.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8113757     DOI: 10.1099/0022-1317-75-2-363

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  17 in total

1.  The class II membrane glycoprotein G of bovine respiratory syncytial virus, expressed from a synthetic open reading frame, is incorporated into virions of recombinant bovine herpesvirus 1.

Authors:  G Kühnle; A Heinze; J Schmitt; K Giesow; G Taylor; I Morrison; F A Rijsewijk; J T van Oirschot; G M Keil
Journal:  J Virol       Date:  1998-05       Impact factor: 5.103

2.  Chimeric bovine respiratory syncytial virus with glycoprotein gene substitutions from human respiratory syncytial virus (HRSV): effects on host range and evaluation as a live-attenuated HRSV vaccine.

Authors:  U J Buchholz; H Granzow; K Schuldt; S S Whitehead; B R Murphy; P L Collins
Journal:  J Virol       Date:  2000-02       Impact factor: 5.103

3.  Antibody responses against the G and F proteins of bovine respiratory syncytial virus after experimental and natural infections.

Authors:  R S Schrijver; J P Langedijk; W H van der Poel; W G Middel; J A Kramps; J T van Oirschot
Journal:  Clin Diagn Lab Immunol       Date:  1996-09

4.  Primary cytotoxic T-cell responses to bovine respiratory syncytial virus in calves.

Authors:  R M Gaddum; R S Cook; L H Thomas; G Taylor
Journal:  Immunology       Date:  1996-07       Impact factor: 7.397

5.  Evolution of bovine respiratory syncytial virus.

Authors:  J F Valarcher; F Schelcher; H Bourhy
Journal:  J Virol       Date:  2000-11       Impact factor: 5.103

Review 6.  Bovine respiratory syncytial virus (BRSV): a review.

Authors:  L E Larsen
Journal:  Acta Vet Scand       Date:  2000       Impact factor: 1.695

7.  Antigenic structure of the central conserved region of protein G of bovine respiratory syncytial virus.

Authors:  J P Langedijk; R H Meloen; G Taylor; J M Furze; J T van Oirschot
Journal:  J Virol       Date:  1997-05       Impact factor: 5.103

8.  Chimeric bovine respiratory syncytial virus with attachment and fusion glycoproteins replaced by bovine parainfluenza virus type 3 hemagglutinin-neuraminidase and fusion proteins.

Authors:  M B Stope; A Karger; U Schmidt; U J Buchholz
Journal:  J Virol       Date:  2001-10       Impact factor: 5.103

9.  Role of T-lymphocyte subsets in recovery from respiratory syncytial virus infection in calves.

Authors:  G Taylor; L H Thomas; S G Wyld; J Furze; P Sopp; C J Howard
Journal:  J Virol       Date:  1995-11       Impact factor: 5.103

10.  Replication-competent or attenuated, nonpropagating vesicular stomatitis viruses expressing respiratory syncytial virus (RSV) antigens protect mice against RSV challenge.

Authors:  J S Kahn; A Roberts; C Weibel; L Buonocore; J K Rose
Journal:  J Virol       Date:  2001-11       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.